2009
DOI: 10.1016/j.jaut.2008.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Pro-inflammatory genotype as a risk factor for aPL-associated thrombosis: Report of a family with multiple anti-phospholipid positive members

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(10 citation statements)
references
References 22 publications
0
10
0
Order By: Relevance
“…Anti-phospholipid-mediated EC perturbation may represent the first hit responsible for the thrombophilic diathesis in APS, a condition that would favour clotting in the presence of an additional second hit as inflammatory mediators [5,27]. On the other hand, EC dysfunction may also be responsible for an accelerated atherosclerosis as shown in other systemic autoimmune diseases [28].…”
Section: Discussionmentioning
confidence: 99%
“…Anti-phospholipid-mediated EC perturbation may represent the first hit responsible for the thrombophilic diathesis in APS, a condition that would favour clotting in the presence of an additional second hit as inflammatory mediators [5,27]. On the other hand, EC dysfunction may also be responsible for an accelerated atherosclerosis as shown in other systemic autoimmune diseases [28].…”
Section: Discussionmentioning
confidence: 99%
“…More than one‐fourth of biomass‐using women of this study were positive for aCL of the IgG isotype against only 2% positive cases among LPG users. Rise in aCL titer among biomass‐using women is important because it increases the risk of spontaneous abortion (Goel et al., 2006) and thrombosis (De Angelis et al., 2009). Elevated level of anticardiolipin IgG has been found in association with stroke and highly elevated titer (>20 GPL) with first‐ever ischemic stroke (Lien et al., 2006).…”
Section: Discussionmentioning
confidence: 99%
“…Targeting signalling molecules may be helpful, but are likely to cause unwanted side effects given the importance of TLR4 in the immune system. On the other hand, it has confirmed the link between TLR4 SNPs and aPL-mediated thrombosis De Angelis et al, 2009). In APS, where long-term suppression of procoagulant effects of aPL is essential, TLR4 SNPs may open new effective avenues to classify patients according to their different risk categories to progress to the vascular manifestations of the syndrome (Raschi et al, 2008).…”
Section: Potential Immunomodulatory Approaches In Apsmentioning
confidence: 89%